| Date | Title | Description |
| 04.06.2025 | UCLA’s affordable AI-powered magnetic pen for early Parkinson’s diagnosis | Researchers at the University of California, Los Angeles (UCLA) have created a 3D printed pen that detects subtle tremors in handwriting, offering a potential tool for diagnosing Parkinson’s disease.
Co-authored by Professor Jun Chen, the d... |
| 04.11.2024 | Herantis Pharma will present at the BioStock Life Science Summit, November 20 | Herantis Pharma will present at the BioStock Life Science Summit, November 20
Mon, Nov 04, 2024 11:00 CET Report this content
The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. CEO Antti Vuola... |
| 04.07.2023 | Herantis Pharma Plc announcing start of recruitment of healthy volunteers for part 2 of the ongoing Phase 1a clinical study of HER-096 | Herantis Pharma Plc announcing start of recruitment of healthy volunteers for part 2 of the ongoing Phase 1a clinical study of HER-096
Tue, Jul 04, 2023 11:05 CET Report this content
Herantis Pharma Plc
Press release, 4 July 2023 at 12:05 p... |
| 20.06.2023 | Herantis Pharma Oyj: Managers' Transactions – Aki Prihti | Herantis Pharma Oyj: Managers' Transactions – Aki Prihti
Tue, Jun 20, 2023 09:30 CET Report this content
Herantis Pharma Plc
Company release 20 June 2023 at 10:30 EEST
Herantis Pharma Oyj - Managers' Transactions
___________________________... |
| 20.06.2023 | Herantis Pharma Oyj: Managers' Transactions – Frans Wuite | Herantis Pharma Oyj: Managers' Transactions – Frans Wuite
Tue, Jun 20, 2023 09:30 CET Report this content
Herantis Pharma Plc
Company release 20 June 2023 at 10:30 EEST
Herantis Pharma Oyj - Managers' Transactions
__________________________... |
| 20.06.2023 | Herantis Pharma Oyj: Managers' Transactions – Timo Veromaa | Herantis Pharma Oyj: Managers' Transactions – Timo Veromaa
Tue, Jun 20, 2023 09:30 CET Report this content
Herantis Pharma Plc
Company release 20 June 2023 at 10:30 EEST
Herantis Pharma Oyj - Managers' Transactions
_________________________... |
| 20.06.2023 | Herantis Pharma Oyj: Managers' Transactions – Henri Huttunen | Herantis Pharma Oyj: Managers' Transactions – Henri Huttunen
Tue, Jun 20, 2023 09:30 CET Report this content
Herantis Pharma Plc
Company release 20 June 2023 at 10:30 EEST
Herantis Pharma Oyj - Managers' Transactions
_______________________... |
| 09.06.2023 | Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle | Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle
Fri, Jun 09, 2023 13:17 CET Report this content
Herantis Pharma Plc
Company release 9 June 2023 at 14:16 EEST
Herantis Pharma Oyj - Managers' Transactions
____________________________... |
| 09.06.2023 | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto
Fri, Jun 09, 2023 13:15 CET Report this content
Herantis Pharma Plc
Company release 9 June 2023 at EEST
Herantis Pharma Oyj - Managers' Transactions
______________________________... |
| 09.06.2023 | Herantis Pharma Oyj: Managers' Transactions – Henri Huttunen | Herantis Pharma Oyj: Managers' Transactions – Henri Huttunen
Fri, Jun 09, 2023 13:15 CET Report this content
Herantis Pharma Plc
Company release 9 June 2023 at 14:15 EEST
Herantis Pharma Oyj - Managers' Transactions
________________________... |
| 02.06.2023 | Herantis Pharma Plc's board decides on new option rights program for managing director, management team and other key personnel | Herantis Pharma Plc's board decides on new option rights program for managing director, management team and other key personnel
Fri, Jun 02, 2023 14:00 CET Report this content
Herantis Pharma Plc
Company release, 2 June 2023 at 3:00 p.m. EE... |
| 23.05.2023 | Herantis Pharma to participate in Redeye Hosted Events: Investor Lunch and Redeye Growth Day | Herantis Pharma to participate in Redeye Hosted Events: Investor Lunch and Redeye Growth Day
Tue, May 23, 2023 09:00 CET Report this content
Herantis Pharma Plc, Press Release, 23 May 2023 at 10:00 A.M. EEST
Herantis Pharma Plc (“Herantis”)... |
| 02.05.2023 | Herantis Pharma to participate in Bio€quity Europe 2023 in Dublin May 2023 | Herantis Pharma to participate in Bio€quity Europe 2023 in Dublin May 2023
Tue, May 02, 2023 10:45 CET Report this content
Herantis Pharma Plc, Press Release, 2 May 2023 at 11:45 A.M. EEST
Herantis Pharma Plc (“Herantis”), a clinical-stage ... |
| 20.04.2023 | Decisions of Herantis Pharma Plc’s Annual General Meeting of shareholders | Decisions of Herantis Pharma Plc’s Annual General Meeting of shareholders
Thu, Apr 20, 2023 12:35 CET Report this content
Herantis Pharma Plc
Company release, 20 April 2023 at 1:35 p.m. Eastern European Summer Time
Herantis Pharma Plc's (“H... |
| 19.04.2023 | Herantis Pharma announces first healthy volunteer dosed in the Phase 1a clinical study for the Parkinson’s disease drug candidate, HER-096 | Herantis Pharma announces first healthy volunteer dosed in the Phase 1a clinical study for the Parkinson’s disease drug candidate, HER-096
Wed, Apr 19, 2023 10:00 CET Report this content
Herantis Pharma Plc, Press release, 19 April 2023 at ... |
| 12.04.2023 | Herantis Pharma has signed European Innovation Council (EIC) Accelerator grant agreement | Herantis Pharma has signed European Innovation Council (EIC) Accelerator grant agreement
Wed, Apr 12, 2023 07:00 CET Report this content
Herantis Pharma Plc, Press release, 12 April 2023 at 08:00 a.m. EEST
Herantis will receive €2.5 million... |
| 06.04.2023 | Herantis Pharma to participate in Nordic Health Summit Japan 2023 | Herantis Pharma to participate in Nordic Health Summit Japan 2023
Thu, Apr 06, 2023 08:00 CET Report this content
Herantis Pharma Plc, Press Release, 6 April 2023 at 09:00 A.M. EEST
Herantis Pharma Plc (“Herantis”), developing disease-modif... |
| 28.03.2023 | Notice to Convene Herantis Pharma Plc's Annual General Meeting of Shareholders | Notice to Convene Herantis Pharma Plc's Annual General Meeting of Shareholders
Tue, Mar 28, 2023 12:46 CET Report this content
Notice to Convene Herantis Pharma Plc's Annual General Meeting of Shareholders
Herantis Pharma Plc Company releas... |
| 28.03.2023 | Herantis Pharma published the Annual report for 2022 | Herantis Pharma published the Annual report for 2022
Tue, Mar 28, 2023 07:00 CET Report this content
Herantis Pharma Plc
Company Release, March 28, 2023, at 8:00 a.m. EEST/7:00 a.m. CEST
Herantis Pharma Plc (“Herantis”), a company developin... |
| 09.03.2023 | Herantis Pharma to participate in Bio-Europe Spring and AD/PD 2023 | Herantis Pharma to participate in Bio-Europe Spring and AD/PD 2023
Thu, Mar 09, 2023 08:00 CET Report this content
Herantis Pharma Plc, Press Release, 9 March 2023 at 09:00 A.M. EET
Herantis Pharma Plc (“Herantis”), developing disease-modif... |
| 08.03.2023 | CORRECTION: Herantis publishes 2H & FY 2022 Report | CORRECTION: Herantis publishes 2H & FY 2022 Report
Wed, Mar 08, 2023 12:57 CET Report this content
Correction to release sent on March 2nd, 2023, at 8:00 a.m. EET: the release category has been updated by removal of “insider informati... |
| 02.03.2023 | Herantis publishes 2H & FY 2022 Report | Herantis publishes 2H & FY 2022 Report
Thu, Mar 02, 2023 07:00 CET Report this content
Herantis Pharma Plc
Company Release, March 2, 2023, at 8:00 a.m. EET/7:00 a.m. CET
“We made good progress in 2022 achieving encouraging preclinical r... |
| 21.02.2023 | Herantis Pharma: Invitation to 2H & FY 2022 report webinar on March 2, 2023 | Herantis Pharma: Invitation to 2H & FY 2022 report webinar on March 2, 2023
Tue, Feb 21, 2023 12:00 CET Report this content
Herantis Pharma Plc, Company release, 21 February 2023 at 1:00 p.m. EET
Herantis Pharma Plc (“Herantis”), a comp... |
| 20.02.2023 | Herantis Pharma announces approval of Clinical Trial Application (CTA) for a Phase 1 study for HER-096 | Herantis Pharma announces approval of Clinical Trial Application (CTA) for a Phase 1 study for HER-096
Mon, Feb 20, 2023 12:00 CET Report this content
Herantis Pharma Plc, Press release, 20 February 2023 at 13:00p.m. EET
Herantis will initi... |
| 20.01.2023 | Proposals of the Shareholders' Nomination Committee to Herantis Pharma Plc's Annual General Meeting 2023 | Proposals of the Shareholders' Nomination Committee to Herantis Pharma Plc's Annual General Meeting 2023
Fri, Jan 20, 2023 09:00 CET Report this content
Herantis Pharma Plc Company release 20 January 2023 at 10:00 a.m. EET
The Shareholders'... |
| 19.01.2023 | Herantis Pharma: Key takeaways from todays R&D update webinar | Herantis Pharma: Key takeaways from todays R&D update webinar
Thu, Jan 19, 2023 12:00 CET Report this content
Herantis Pharma Plc, Press release, 19 January 2023 at 1:00 pm EST
Antti Vuolanto, CEO of Herantis Pharma said, “We made good ... |
| 12.01.2023 | Herantis Pharma to host a R&D update webinar on January 19, 2023 | Herantis Pharma to host a R&D update webinar on January 19, 2023
Thu, Jan 12, 2023 08:00 CET Report this content
Herantis Pharma Plc, Press release, 12 January 2023 at 9:00 AM EEST
Link to the R&D update webinar (14:00-15:00 EET/13:... |
| 04.01.2023 | Herantis Pharma to participate in Biotech Showcase and Sachs virtual conferences | Herantis Pharma to participate in Biotech Showcase and Sachs virtual conferences
Wed, Jan 04, 2023 08:00 CET Report this content
Herantis Pharma Plc, Press Release, 4 January 2023 at 09:00 A.M. EET
Herantis Pharma Plc (“Herantis”), developi... |
| 22.12.2022 | Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle | Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle
Thu, Dec 22, 2022 10:00 CET Report this content
Herantis Pharma Plc
Company release 22 December 2022 at 11:00 EEST
Herantis Pharma Oyj - Managers' Transactions
_______________________... |
| 22.12.2022 | Herantis Pharma Oyj: Managers' Transactions – Henri Huttunen | Herantis Pharma Oyj: Managers' Transactions – Henri Huttunen
Thu, Dec 22, 2022 10:00 CET Report this content
Herantis Pharma Plc
Company release 22 December 2022 at 11:00 EEST
Herantis Pharma Oyj - Managers' Transactions
___________________... |
| 22.12.2022 | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto
Thu, Dec 22, 2022 10:00 CET Report this content
Herantis Pharma Plc
Company release 22 December 2022 at 11:00 EEST
Herantis Pharma Oyj - Managers' Transactions
___________________... |
| 20.12.2022 | Herantis Pharma to host a R&D update webinar January 19, 2023 | Herantis Pharma to host a R&D update webinar January 19, 2023
Tue, Dec 20, 2022 12:00 CET Report this content
Herantis Pharma Plc
Press release 20 Dec 2022 at 1:00 p.m. EET
Save the date: Virtual R&D update webinar January 19, 2023 ... |
| 19.12.2022 | Herantis Pharma announces submission of a Clinical Trial Application (CTA) for a Phase 1 study for HER-096 | Herantis Pharma announces submission of a Clinical Trial Application (CTA) for a Phase 1 study for HER-096
Mon, Dec 19, 2022 13:15 CET Report this content
Herantis Pharma Plc, Press release, 19 December 2022 at 2:15 p.m. EET
The purpose of ... |
| 19.12.2022 | Herantis Pharma selected for European Innovation Council (EIC) grant of €2.5 million | Herantis Pharma selected for European Innovation Council (EIC) grant of €2.5 million
Mon, Dec 19, 2022 16:30 CET Report this content
Herantis Pharma Plc, Company release, insider information, 19 December 2022 at 5:28 p.m. EET
The EIC will, ... |
| 15.12.2022 | Herantis Pharma’s financial calendar and annual general meeting for 2023 | Herantis Pharma’s financial calendar and annual general meeting for 2023
Thu, Dec 15, 2022 08:00 CET Report this content
Herantis Pharma Plc
Company release 15 Dec 2022 at 9:00 am EET
Herantis Pharma Plc (“Herantis”), an innovative biotech ... |
| 07.12.2022 | Herantis Pharma to participate in Inderes Life Science evening | Herantis Pharma to participate in Inderes Life Science evening
Wed, Dec 07, 2022 08:00 CET Report this content
Herantis Pharma Plc, Press Release, 7 December 2022 at 09:00 A.M. EEST
Herantis Pharma Plc (“Herantis”), developing disease modif... |
| 05.12.2022 | Herantis Pharma: Approved delisting application regarding the secondary listing on the Nasdaq First North Growth Market Sweden | Herantis Pharma: Approved delisting application regarding the secondary listing on the Nasdaq First North Growth Market Sweden
Mon, Dec 05, 2022 08:00 CET Report this content
Herantis Pharma Plc, Company release, 5 December 2022 at 09:00 EE... |
| 01.12.2022 | Herantis Pharma applies for delisting regarding the secondary listing of its shares from Nasdaq First North Growth Market Sweden | Herantis Pharma applies for delisting regarding the secondary listing of its shares from Nasdaq First North Growth Market Sweden
Thu, Dec 01, 2022 10:30 CET Report this content
Herantis Pharma Plc, Company release, 1 December 2022 at 11:30 ... |
| 07.11.2022 | Herantis Pharma to participate in upcoming November investor conferences | Herantis Pharma to participate in upcoming November investor conferences
Mon, Nov 07, 2022 08:00 CET Report this content
Herantis Pharma Plc, Press Release, 7 November 2022 at 09:00 A.M. EEST
Herantis Pharma Plc (“Herantis”), developing dis... |
| 26.10.2022 | Composition of Herantis Pharma Plc’s Shareholders’ Nomination Committee | Composition of Herantis Pharma Plc’s Shareholders’ Nomination Committee
Wed, Oct 26, 2022 16:30 CET Report this content
Herantis Pharma Plc, Company release, 26 October 2022 at 5:30 p.m. EET
The following members have been appointed to Hera... |
| 21.09.2022 | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto
Wed, Sep 21, 2022 16:00 CET Report this content
Herantis Pharma Plc
Company release 21 September 2022 at 5:00pm EEST
Herantis Pharma Oyj - Managers' Transactions
_________________... |
| 15.09.2022 | Herantis Pharma Plc's board decides on new option rights program for managing director, management team and other key personnel | Herantis Pharma Plc's board decides on new option rights program for managing director, management team and other key personnel
Thu, Sep 15, 2022 14:30 CET Report this content
Herantis Pharma Plc
Company release, 15 September 2022 at 3:30 p... |
| 07.09.2022 | Herantis Pharma to Participate in the Nordic Life Science Days, Sweden | Herantis Pharma to Participate in the Nordic Life Science Days, Sweden
Wed, Sep 07, 2022 08:00 CET Report this content
Herantis Pharma Plc, Press Release, 7 August 2022 at 09:00 EEST
Herantis Pharma Plc (“Herantis”), developing disease modi... |
| 06.09.2022 | Tiny 3D printed backpack turns insects into Bluetooth-controlled cyborgs | Researchers at Japan’s RIKEN Center for Emergent Matter Science (CEMS) have used 3D printing to create a device which transforms cockroaches into remote control cyborgs.
3D printed from an elastic polymer that allows it to follow the curved... |
| 04.08.2022 | Herantis Pharma: Invitation to 1H 2022 Report on August 25, 2022 | Herantis Pharma: Invitation to 1H 2022 Report on August 25, 2022
Thu, Aug 04, 2022 08:00 CET Report this content
Herantis Pharma Plc, Press Release, August 4, 2022 at 09:00 EEST
Herantis Pharma Plc("Herantis") an innovative biotec... |
| 08.07.2022 | Antti Vuolanto appointed as CEO of Herantis as of 22 July 2022 | Antti Vuolanto appointed as CEO of Herantis as of 22 July 2022
Fri, Jul 08, 2022 12:00 CET Report this content
Herantis Pharma Plc
Company release, Inside information, 8 July 2022 at 1 p.m. EEST
The Board of Directors of Herantis Pharma Plc... |
| 15.06.2022 | Herantis Pharma Oyj: Managers' Transactions – Sigrid Booms | Herantis Pharma Oyj: Managers' Transactions – Sigrid Booms
Wed, Jun 15, 2022 16:15 CET Report this content
Herantis Pharma Plc
Company release 15 June 2022 at 5:15 pm EEST
Herantis Pharma Oyj - Managers' Transactions
_______________________... |
| 02.06.2022 | New shares in Herantis Pharma Plc registered with the trade register | New shares in Herantis Pharma Plc registered with the trade register
Thu, Jun 02, 2022 10:10 CET Report this content
Herantis Pharma Plc
Company release, 2 June 2022 at 11:10 a.m. EEST
THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PU... |
| 02.06.2022 | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto
Thu, Jun 02, 2022 15:00 CET Report this content
Herantis Pharma Plc
Company release 2 June 2022 at 16:00pm EEST
Herantis Pharma Oyj - Managers' Transactions
______________________... |
| 02.06.2022 | Herantis Pharma Oyj: Managers' Transactions – Frans Wuite | Herantis Pharma Oyj: Managers' Transactions – Frans Wuite
Thu, Jun 02, 2022 15:00 CET Report this content
Herantis Pharma Plc
Company release 2 June 2022 at 4:00pm EEST
Herantis Pharma Oyj - Managers' Transactions
__________________________... |
| 02.06.2022 | Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle | Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle
Thu, Jun 02, 2022 15:00 CET Report this content
Herantis Pharma Plc
Company release 2 June 2022 at 16:00pm EEST
Herantis Pharma Oyj - Managers' Transactions
__________________________... |
| 01.06.2022 | Final results of Herantis Pharma Plc's fully subscribed rights issue | Final results of Herantis Pharma Plc's fully subscribed rights issue
Wed, Jun 01, 2022 19:00 CET Report this content
Herantis Pharma Plc
Company release, 1 June 2022 at 8:00 p.m. EEST
THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUB... |
| 30.05.2022 | Preliminary results of Herantis Pharma Plc's fully subscribed rights issue | Preliminary results of Herantis Pharma Plc's fully subscribed rights issue
Mon, May 30, 2022 18:45 CET Report this content
Herantis Pharma Plc
Company release, 30 May 2022 at 7:45 p.m. EEST
THE INFORMATION CONTAINED IN THIS RELEASE IS NOT F... |
| 27.05.2022 | Herantis Pharma to Participate in Redeye Growth Day in June | Herantis Pharma to Participate in Redeye Growth Day in June
Fri, May 27, 2022 12:00 CET Report this content
Herantis Pharma Plc, Press Release, 27 May 2022 at 13:00 EEST
Herantis Pharma Plc (“Herantis”), developing disease modifying therapi... |
| 13.05.2022 | Herantis Pharma Oyj: Managers' Transactions – Frans Wuite | Herantis Pharma Oyj: Managers' Transactions – Frans Wuite
Fri, May 13, 2022 08:00 CET Report this content
Herantis Pharma Plc
Company release 13 May 2022 at 9:00am EEST
Herantis Pharma Oyj - Managers' Transactions
__________________________... |
| 13.05.2022 | Herantis Pharma Oyj: Managers' Transactions – Timo Veromaa | Herantis Pharma Oyj: Managers' Transactions – Timo Veromaa
Fri, May 13, 2022 08:00 CET Report this content
Herantis Pharma Plc
Company release 13 May 2022 at 9:00am EEST
Herantis Pharma Oyj - Managers' Transactions
_________________________... |
| 13.05.2022 | Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle | Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle
Fri, May 13, 2022 08:00 CET Report this content
Herantis Pharma Plc
Company release 13 May 2022 at 9:00am EEST
Herantis Pharma Oyj - Managers' Transactions
___________________________... |
| 13.05.2022 | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto
Fri, May 13, 2022 08:00 CET Report this content
Herantis Pharma Plc
Company release 13 May 2022 at 9:00am EEST
Herantis Pharma Oyj - Managers' Transactions
_______________________... |
| 12.05.2022 | Herantis Pharma: Invitation to a virtual company presentation on May 19, 2022 | Herantis Pharma: Invitation to a virtual company presentation on May 19, 2022
Thu, May 12, 2022 10:00 CET Report this content
Herantis Pharma Plc, Press release, 12 May 2022 at 11:00 EEST
THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR... |
| 03.05.2022 | Herantis Pharma Plc's Board of Directors resolved on a rights issue and publishes the terms and conditions of the rights issue | Herantis Pharma Plc's Board of Directors resolved on a rights issue and publishes the terms and conditions of the rights issue
Tue, May 03, 2022 10:23 CET Report this content
Herantis Pharma Plc
Company release, 3 May 2022 at 11:20 a.m. EES... |
| 03.05.2022 | Herantis Pharma Plc's publishes a prospectus relating to its rights issue | Herantis Pharma Plc's publishes a prospectus relating to its rights issue
Tue, May 03, 2022 18:50 CET Report this content
Herantis Pharma Plc
Company release, 3 May 2022 at 7:50 p.m. EEST
THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR... |
| 02.05.2022 | Herantis Pharma to Participate in Investor and Partnering Conferences | Herantis Pharma to Participate in Investor and Partnering Conferences
Mon, May 02, 2022 10:15 CET Report this content
Herantis Pharma Plc, Press Release, 2 May 2022 at 11:15 EEST
Herantis Pharma Plc (“Herantis”), developing disease modifyin... |
| 28.04.2022 | Herantis Pharma Announces Successful HER-096 Initial Results with Blood-Brain Barrier Penetration in Dogs | Herantis Pharma Announces Successful HER-096 Initial Results with Blood-Brain Barrier Penetration in Dogs
Thu, Apr 28, 2022 08:00 CET Report this content
Herantis Pharma Plc
Press release 28 Apr 2022 at 9:00 am EEST
Herantis Pharma Plc (“He... |
| 21.04.2022 | Decisions of Herantis Pharma Plc’s Annual General Meeting of shareholders | Decisions of Herantis Pharma Plc’s Annual General Meeting of shareholders
Thu, Apr 21, 2022 12:20 CET Report this content
Herantis Pharma Plc
Company release, 21 April 2022 at 1:20 p.m. Eastern European Summer Time
Herantis Pharma Plc's (“H... |
| 14.04.2022 | Herantis Pharma Oyj: Managers' Transactions – Henri Huttunen | Herantis Pharma Oyj: Managers' Transactions – Henri Huttunen
Thu, Apr 14, 2022 15:00 CET Report this content
Herantis Pharma Plc
Company release 14 April 2022 at 4:00 pm EEST
Herantis Pharma Oyj – Managers’ Transactions
____________________... |
| 14.04.2022 | Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle | Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle
Thu, Apr 14, 2022 15:00 CET Report this content
Herantis Pharma Plc
Company release 14 April 2022 at 4:00pm EEST
Herantis Pharma Oyj – Managers’ Transactions
_________________________... |
| 14.04.2022 | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto | Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto
Thu, Apr 14, 2022 15:00 CET Report this content
Herantis Pharma Plc
Company release 14 April 2022 at 4:00 pm EEST
Herantis Pharma Oyj – Managers’ Transactions
____________________... |
| 14.04.2022 | Herantis Pharma Oyj: Managers' Transactions – Sigrid Booms | Herantis Pharma Oyj: Managers' Transactions – Sigrid Booms
Thu, Apr 14, 2022 15:00 CET Report this content
Herantis Pharma Plc
Company release 14 April 2022 at 4:00 pm EEST
Herantis Pharma Oyj – Managers’ Transactions
______________________... |
| 05.04.2022 | Correction to the notice of Annual General Meeting of Shareholders of Herantis Pharma Plc | Correction to the notice of Annual General Meeting of Shareholders of Herantis Pharma Plc
Tue, Apr 05, 2022 11:50 CET Report this content
Herantis Pharma Plc Company release 5 April 2022 at 12:50 p.m. EEST
Herantis Pharma Plc released on 29... |
| 05.04.2022 | Herantis Pharma Plc: Managers' transactions – Inveni Life Sciences Fund I Ky | Herantis Pharma Plc: Managers' transactions – Inveni Life Sciences Fund I Ky
Tue, Apr 05, 2022 13:30 CET Report this content
Herantis Pharma Plc Company release, 5 April 2022 at 2:30 p.m. EEST
Herantis Pharma Oyj - Managers' Transactions
__... |
| 05.04.2022 | Herantis Pharma Plc: Managers' transactions – Inveni Capital Oy | Herantis Pharma Plc: Managers' transactions – Inveni Capital Oy
Tue, Apr 05, 2022 13:42 CET Report this content
Herantis Pharma Plc Company release, 5 April 2022 at 2:40 p.m. EEST
Herantis Pharma Oyj - Managers' Transactions
_______________... |
| 05.04.2022 | Herantis Pharma Plc: Managers' transactions – Inveni Fund I Oy | Herantis Pharma Plc: Managers' transactions – Inveni Fund I Oy
Tue, Apr 05, 2022 13:36 CET Report this content
Herantis Pharma Plc Company release, 5 April 2022 at 2:34 p.m. EEST
Herantis Pharma Oyj - Managers' Transactions
________________... |
| 04.04.2022 | Herantis Pharma Plc: 975,000 new shares registered with the trade register | Herantis Pharma Plc: 975,000 new shares registered with the trade register
Mon, Apr 04, 2022 11:30 CET Report this content
Herantis Pharma Plc
Company release, 4 April 2022 at 12:30 pm EEST
THE INFORMATION CONTAINED IN THIS RELEASE IS NOT F... |
| 30.03.2022 | Herantis Pharma Plc successfully completes a directed share issue raising EUR 1.46 million | Herantis Pharma Plc successfully completes a directed share issue raising EUR 1.46 million
Wed, Mar 30, 2022 15:00 CET Report this content
Herantis Pharma Plc
Company release, 30 March 2022 at 4:00 p.m. EEST
THE INFORMATION CONTAINED IN THI... |
| 29.03.2022 | Herantis Pharma Plc is contemplating carrying out a directed share issue and a rights issue | Herantis Pharma Plc is contemplating carrying out a directed share issue and a rights issue
Tue, Mar 29, 2022 18:45 CET Report this content
Herantis Pharma Plc
Company release, inside information, 29 March 2022 at 7:45 p.m. EEST
THE INFORMA... |
| 29.03.2022 | Notice to Convene Herantis Pharma Plc's Annual General Meeting of Shareholders | Notice to Convene Herantis Pharma Plc's Annual General Meeting of Shareholders
Tue, Mar 29, 2022 18:55 CET Report this content
Herantis Pharma Plc Company release 29 March 2022 at 7:55 p.m. EEST
Notice is given to the shareholders of Herant... |
| 24.03.2022 | Herantis Pharma Announces Successful HER-096 Initial Results with Nanoform Technology | Herantis Pharma Announces Successful HER-096 Initial Results with Nanoform Technology
Thu, Mar 24, 2022 08:00 CET Report this content
Herantis Pharma Plc
Press release 24 Mar 2022 at 09:00 am EET
Herantis Pharma Plc (“Herantis”), an innovat... |
| 23.03.2022 | Herantis Pharma published the Annual report for 2021 | Herantis Pharma published the Annual report for 2021
Wed, Mar 23, 2022 07:00 CET Report this content
Herantis Pharma Plc
Company release 23 Mar 2022 at 08:00 am EET
Herantis Pharma Plc (“Herantis”), an innovative biotech company developing ... |
| 14.03.2022 | Proposals of the Shareholders' Nomination Committee to Herantis Pharma Plc's Annual General Meeting 2022 | Proposals of the Shareholders' Nomination Committee to Herantis Pharma Plc's Annual General Meeting 2022
Mon, Mar 14, 2022 11:21 CET Report this content
Herantis Pharma Plc Company release 14 March 2022 at 12:20 p.m. EET
The Shareholders' N... |
| 08.03.2022 | Herantis Pharma to Participate in the Upcoming Investor and Partnering Conference | Herantis Pharma to Participate in the Upcoming Investor and Partnering Conference
Tue, Mar 08, 2022 08:00 CET Report this content
Herantis Pharma Plc, Press Release, 8 March 2022 at 09:00 EET
Herantis Pharma Plc (“Herantis”), developing dis... |
| 03.03.2022 | Herantis Publishes Year-End Report for 2021 | Herantis Publishes Year-End Report for 2021
Thu, Mar 03, 2022 07:00 CET Report this content
Herantis Pharma Plc, Company Release, inside information, 3 March 2022 at 08:00 EET
“An important milestone for Herantis in 2021 was the selection o... |
| 07.02.2022 | Invitation to Presentation of Herantis Pharma’s 2H and Full Year Report 2021 | Invitation to Presentation of Herantis Pharma’s 2H and Full Year Report 2021
Mon, Feb 07, 2022 08:00 CET Report this content
Herantis Pharma Plc, Press Release, 7 February 2022 at 09:00 EET
Herantis Pharma Plc (“Herantis”), developing disea... |
| 20.01.2022 | CEO transition; Herantis to focus on HER-096 | CEO transition; Herantis to focus on HER-096 Thu, Jan 20, 2022 15:32 CET
Herantis Pharma Plc, Company Release, inside information, 20 January 2022 at 16:30 EET
Herantis Pharma Plc's ("Herantis") Board of Directors has appointed Fr... |
| 20.01.2022 | CEO transition; Herantis to focus on HER-096 | CEO transition; Herantis to focus on HER-096 Thu, Jan 20, 2022 15:31 CET
Herantis Pharma Plc, Company Release, inside information, 20 January 2022 at 16:30 EET
Herantis Pharma Plc's ("Herantis") Board of Directors has appointed Fr... |
| 13.01.2022 | Herantis Marks A Successful 2021; An Ambitious and Promising 2022 Ahead to Advance Robust CNS Pipeline | Herantis Marks A Successful 2021; An Ambitious and Promising 2022 Ahead to Advance Robust CNS Pipeline Thu, Jan 13, 2022 08:00 CET
Herantis Pharma Plc, Press Release, 13 January 2022 at 09:00 EET
Dr Craig Cook, CEO, commented ”2021 was inde... |
| 13.01.2022 | Herantis Marks A Successful 2021; An Ambitious and Promising 2022 Ahead to Advance Robust CNS Pipeline | Herantis Pharma Plc, Press Release, 13 January 2022 at 09:00 EET
Dr
Craig Cook, CEO, commented "2021 was indeed a defining year for Herantis as we move into the next chapter for the company and our programs. The year saw us focus all o... |
| 03.01.2022 | Herantis Pharma to Participate in the Upcoming Investor Conferences | Herantis Pharma to Participate in the Upcoming Investor Conferences Mon, Jan 03, 2022 11:45 CET
Herantis Pharma Plc, Press Release, 3 January 2022 at 12:45 EET
Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for de... |
| 15.11.2021 | Composition of Herantis Pharma Plc's Shareholders' Nomination Committee | Composition of Herantis Pharma Plc's Shareholders' Nomination Committee Mon, Nov 15, 2021 16:00 CET
Herantis Pharma Plc, Company release, 15 November 2021 at 5:00 p.m. EET
The following members have been appointed to Herantis Pharma's Share... |
| 03.11.2021 | Herantis Pharma to Participate in the Upcoming Investor Conferences | Herantis Pharma to Participate in the Upcoming Investor Conferences Wed, Nov 03, 2021 11:14 CET
Herantis Pharma Plc, Press Release, 3 November 2021 at 12:00 EET
Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for d... |
| 26.10.2021 | Herantis Pharma Provides R&D Update and Information About New Biomarker Program | Herantis Pharma Provides R&D Update and Information About New Biomarker Program Tue, Oct 26, 2021 07:04 CET
Herantis Pharma Plc, Press Release, 26 October 2021 at 08:00 EEST
Herantis Pharma Plc (“Herantis or the Company”), focusing on d... |
| 25.10.2021 | Herantis Pharma Oyj : Announces Members of Scientific Advisory Board | Herantis Pharma Plc, Press Release, 25 October 2021 at 9:00 EEST
Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced the formation of a Scientific ... |
| 25.10.2021 | Herantis Pharma Announces Members of Scientific Advisory Board | Herantis Pharma Announces Members of Scientific Advisory Board Mon, Oct 25, 2021 08:00 CET
Herantis Pharma Plc, Press Release, 25 October 2021 at 9:00 EEST
Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debili... |
| 30.09.2021 | Herantis Pharma Oyj : Announces Paper in Journal Genes on biomarker -driven approaches in Parkinson's Disease | Herantis Pharma Plc, Press Release, 30 September 2021 at 11:45 EEST
Herantis Pharma Plc ("Herantis"), focusing on disease-modifying therapies for debilitating neurodegenerative diseases, today announced that a review describing ge... |
| 30.09.2021 | Herantis Pharma Oyj : Announces Paper in Journal Genes on biomarker -driven approaches in Parkinson's Disease | Herantis Pharma Announces Paper in Journal Genes on biomarker-driven approaches in Parkinson's Disease
Herantis Pharma Plc, Press Release, 30 September 2021 at 12:00 EEST
Herantis Pharma Plc ("Herantis"), focusing on disease-modif... |
| 30.09.2021 | Herantis Pharma Announces Paper in Journal Genes on biomarker -driven approaches in Parkinson’s Disease | Herantis Pharma Announces Paper in Journal Genes on biomarker -driven approaches in Parkinson’s Disease Thu, Sep 30, 2021 11:00 CET
Herantis Pharma Plc, Press Release, 30 September 2021 at 12:00 EEST
Herantis Pharma Plc (“Herantis”), focusi... |
| 29.09.2021 | Herantis Pharma to Participate in the Upcoming Investor Conferences | Herantis Pharma to Participate in the Upcoming Investor Conferences Wed, Sep 29, 2021 11:00 CET
Herantis Pharma Plc, Press Release, 29 September 2021 at 12:00 EEST
Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies fo... |
| 17.09.2021 | Herantis Pharma Announces Poster and Presentation at MDS Virtual Congress 2021 | Herantis Pharma Announces Poster and Presentation at MDS Virtual Congress 2021 Fri, Sep 17, 2021 08:00 CET
Herantis Pharma Plc, Press Release, 17 September 2021 at 9:00 EEST
First-in-Man Clinical Trial of Intraputamenal CDNF in Parkinson’s ... |
| 17.09.2021 | Herantis Pharma Oyj : Announces Poster and Presentation at MDS Virtual Congress 2021 | Herantis Pharma Plc, Press Release, 17 September 2021 at 9:00 EEST
First-in-Man Clinical Trial of Intraputamenal CDNF in Parkinson's disease Finds a Consorted Biomarker Response in a Subgroup of Subjects.
Herantis Pharma Plc ("Herantis... |
| 16.09.2021 | Herantis Pharma Plc: 1,346,500 new shares registered with the trade register | Herantis Pharma Plc: 1,346,500 new shares registered with the trade register Thu, Sep 16, 2021 13:50 CET
Herantis Pharma Plc
Company release, 16 September 2021 at 14:50 p.m. Eastern European Summer Time
THE INFORMATION CONTAINED IN THIS REL... |
| 15.09.2021 | Herantis Pharma Oyj : Plc launches an accelerated book building process to raise a minimum of EUR 4 million through a private placement of new shares | Herantis Pharma Plc
Company release, inside information, 15 September 2021 at 6:39 p.m. Eastern European
Summer Time
THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRA... |
